Once versus twice daily mesalazine to induce remission in paediatric ulcerative colitis: an investigator-initiated randomised controlled trial

被引：0
|
作者：
Turner, D. [1 ]
Yerushalmi, B. [2 ]
Kori, M. [3 ]
Broide, E. [4 ]
Mozer-Glassberg, Y. [5 ]
Shaoul, R. [6 ]
Kolho, K-L [7 ]
Shteyer, E. [8 ]
Shamaly, H. [9 ]
Ledder, O. [10 ]
Cohen, S. [11 ]
Peleg, S. [12 ]
On, A. [13 ]
Levine, A. [14 ]
机构：
[1] Shaare Zedek Med Ctr, Inst Paediat Gastroenterol, Jerusalem, Israel
[2] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[3] Kaplan Hosp, IL-76100 Rehovot, Israel
[4] Asaff Harofeh, Tel Aviv, Israel
[5] Schneiders Children Hosp, Petah Tiqwa, Israel
[6] Rambam Med Ctr, Haifa, Israel
[7] Univ Helsinki, Childrens Hosp, Helsinki, Finland
[8] Hadassah Med Ctr, Kiryat Haddasah, IL-91120 Jerusalem, Israel
[9] French Hosp, Nazareth, Israel
[10] Shaare Zedek Med Ctr, Jerusalem, Israel
[11] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[12] Emek Med Ctr, Afula, Israel
[13] Poria, Tiberias, Israel
[14] Wolfson Med Ctr, Holon, Israel
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P623
引用
收藏
页码：S416 / S416
页数：1
相关论文
共 50 条
  • [1] Once-Versus Twice-daily Mesalazine to Induce Remission in Paediatric Ulcerative Colitis: A Randomised Controlled Trial
    Turner, Dan
    Yerushalmi, Baruch
    Kori, Michal
    Broide, Efrat
    Mozer-Glassberg, Yael
    Shaoul, Ron
    Kolho, Kaija-Leena
    Shteyer, Eyal
    Shamaly, Hussein
    Ledder, Oren
    Cohen, Shlomi
    Peleg, Sarit
    On, Avi
    Levine, Arie
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (05): : 527 - 533
  • [2] Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis
    Kamm, M. A.
    Lichtenstein, G. R.
    Sandborn, W. J.
    Schreiber, S.
    Lees, K.
    Barrett, K.
    Joseph, R.
    GUT, 2008, 57 (07) : 893 - 902
  • [3] Treatment acceptability in a randomised controlled trial of once-daily or twice-daily mesalazine (Pentasa) for the maintenance of remission in ulcerative colitis
    Dignass, Axel U.
    Bokemeyer, Bernd
    Adamek, H. E.
    Mross, Michael R.
    Vinter-Jensen, Lars
    Boerner, N.
    Silvennoinen, Jouni
    Tan, T. G.
    Oudkerk-Pool, M.
    Stijnen, Theo
    Dietel, Peter
    Klugmann, Tobias
    Veerman, Henri
    GASTROENTEROLOGY, 2008, 134 (04) : A495 - A496
  • [4] Once-versus twice-daily mesalazine (pentasa) granules for the maintenance of remission in ulcerative colitis: Results from a multinational randomised controlled trial
    Dignass, A.
    Veerman, H.
    GUT, 2008, 57 : A1 - A1
  • [5] Once-Daily Versus Twice-Daily Mesalazine for Active Ulcerative Colitis: Efficacy Results From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study
    Flourie, Bernard
    Hagege, Herve
    Tucat, Gilbert
    Masclee, Ad
    Dewit, Olivier
    Probert, Chris
    Broberg, Per
    Djamila, Aoucheta
    GASTROENTEROLOGY, 2012, 142 (05) : S197 - S197
  • [6] Pentasa (mesalazine) once or twice daily for the management of maintenance of remission of ulcerative colitis: Demographic and baseline data of a 12 month single blind randomised controlled trial
    Dignass, Axell
    Stijnen, Theo
    Mross, Michael R.
    Vermeire, Severine
    Veerman, Henri
    Bhatt, Aomesh
    GASTROENTEROLOGY, 2007, 132 (04) : A502 - A503
  • [7] The PODIUM trial of once-daily versus twice-daily mesalazine dosing in ulcerative colitis: maintenance of mucosal healing
    Lukas, Milan
    Muls, Vinciane
    Silvennoinen, Jouni
    Pool, Oudkerk Marco
    Befrits, Ragnar
    Broberg, Per
    Dignass, Axel
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 : 74 - 74
  • [8] The PODIUM Trial of Once-Daily Versus Twice-Daily Mesalazine Dosing in Ulcerative Colitis: Maintenance of Mucosal Healing
    Dignass, Axel U.
    Muls, Vinciane
    Silvennoinen, Jouni
    Pool, Marco Oudkerk
    Befrits, Ragnar
    Broberg, Per
    Lukas, Milan
    GASTROENTEROLOGY, 2010, 138 (05) : S520 - S520
  • [9] ONCE DAILY MESALAZINE FOR MAINTAINING REMISSION IS COST-SAVING COMPARED TO TWICE DAILY MESALAZINE: AN ECONOMIC EVALUATION BASED ON THE PODIUM RANDOMISED CONTROLLED TRIAL
    Connolly, M.
    Nielsen, S. K.
    Currie, C. J.
    Poole, C. D.
    VALUE IN HEALTH, 2008, 11 (06) : A521 - A521
  • [10] Maintenance therapy with once-daily 2 g mesalazine (Pentasa) treatment improves remission rates in subjects with ulcerative colitis compared to twice daily 1 g mesalazine: data from a randomised controlled trial
    Oudkerk-Pool, M.
    Dignass, A. U.
    Stijnen, T.
    Veerman, H.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A32 - A33
12345